Auckland-based Fisher & Paykel Healthcare Corp has posted a record half year with net profit surging 86 per cent while revenue jumped 59 per cent, underpinned by products used in non-invasive ventilation as COVID-19 took hold around the globe.
The dual-listed company is a designer and manufacturer of products used in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnoea.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
